Core Viewpoint - RuiLian New Materials is a leading enterprise in the domestic specialized organic materials sector, focusing on R&D, production, and sales of specialized organic materials, with advantages in technology and the entire industry chain [1] Group 1: Business Performance - In Q3 2025, RuiLian New Materials reported revenue of 1.301 billion yuan, ranking 14th in the industry, with the top competitor, Xilong Science, generating 5.324 billion yuan [2] - The main business composition includes display materials at 629 million yuan (77.97%), pharmaceutical intermediates at 150 million yuan (18.63%), and others at 27.4533 million yuan (3.41%) [2] - The net profit for the same period was 281 million yuan, ranking 7th in the industry, with the top competitor, Anji Technology, at 608 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, the asset-liability ratio for RuiLian New Materials was 10.29%, lower than the previous year's 12.07% and the industry average of 28.64%, indicating strong debt repayment capability [3] - The gross profit margin for Q3 2025 was 47.64%, up from 43.30% year-on-year and above the industry average of 31.60%, reflecting strong profitability [3] Group 3: Executive Compensation - The chairman, Liu Xiaochun, received a salary of 1.39 million yuan in 2024, an increase of 490,000 yuan from 2023 [4] - The general manager, Wang Xiaowei, earned 1.38 million yuan in 2024, up by 680,000 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 5.41% to 10,600, while the average number of circulating A-shares held per account increased by 5.72% to 16,400 [5] - The company is expected to see revenue growth from 1.724 billion yuan in 2025 to 2.516 billion yuan in 2027, with net profits projected to rise from 339 million yuan to 494 million yuan over the same period [5]

其进一步称，公司半导体光刻胶单体均系客户定制产品，部分已经量产，部分处于客户验证中。相对于 显示材料产品，光刻胶相关产品的研发和客户验证（小试验证和量产验证）周期更长，虽然公司光刻胶 相关产品目前营收相对较小，但储备产品的种类和数量较多，随着验证通过产品数量的增多及逐步放 量，未来将对公司整体营收产生较大贡献。 8月5日，瑞联新材在互动平台表示，光刻胶材料因其金属离子含量、杂质控制及水含量等方面要求更为 严格客户验证周期普遍较长。目前公司储备有多款光刻胶材料产品，部分光刻胶单体材料已量产，部分 产品处于客户验证阶段。 值得关注的是，瑞联新材早在2023年8月就启动战略布局，计划投资4.91亿元建设光刻胶及高端新材料 产业化项目。该项目由全资子公司大荔海泰负责实施，旨在满足危险化学品和特殊产品的专业化生产需 求，进一步拓展公司产品线和产品种类。 ...

人民财讯8月5日电，瑞联新材(688550)8月5日在互动平台表示，光刻胶材料因其金属离子含量、杂质控 制及水含量等方面要求更为严格，客户验证周期普遍较长。目前公司储备有多款光刻胶材料产品，部分 光刻胶单体材料已量产，部分产品处于客户验证阶段。 ...